Financial Statements

Myriad Genetics, Inc. (MYGN)

$23.12

+1.97 (+9.31%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -1742653-68-
Net Income -27-200513122
Stock Dividends -53--32-10-90
Dividend Paid -----
Retained Earnings -254-1742653-68

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 103574351-
Annual Depreciation 405623157
Capital Expenditure -18-10-9-8-6
Net PPE 125103574351

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -316319417328
New Purchases -88-81-79-61-148
Intangible and Goodwill 316319417328239

Myriad Genetics, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Myriad Genetics, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.